COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ advisory
5/22 PEP, PrEP
ICMR, Indian Council of Medical Research (Advisory) (not included in the study count)
Revised advisory on the use of Hydroxychloroquine (HCQ) as prophylaxis for SARS-CoV-2 infection
Source   PDF   Share   Tweet
Healthcare workers on HCQ prophylaxis less likely to get COVID. Significant dose-response relationship. Extends recommended HCQ prophylaxis to asymptomatic household contacts of cases and frontline workers. Degree of benefit not quantified.

ICMR et al., 5/22/2020, preprint, 1 author.
Details of all 231 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit